世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
トキソプラズマ症検査に関する市場調査：血清学的検査が広く支持され、市場シェア上位を占めるMarket Study on Toxoplasmosis Testing: Serological Tests Widely Preferred and Account for Leading Market Share トキソプラズマ症検査市場レポートスコープ Persistence Market Research社の最新レポート「世界のトキソプラズマ症検査市場」は、市場機会と現在の市場展望を評価し、市場に影響を与える対応するセクションに... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリートキソプラズマ症検査市場レポートスコープPersistence Market Research社の最新レポート「世界のトキソプラズマ症検査市場」は、市場機会と現在の市場展望を評価し、市場に影響を与える対応するセクションに関する詳細な分析と最新情報を提供しています。この調査レポートは、市場の促進要因、阻害要因、動向、機会を含む現在の市場ダイナミクスに関する詳細な洞察を提供しています。市場調査の主な目的は、2023年から2033年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。 市場の成功成長のための重要な指標は、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）を含むこの包括的なレポートで提示され、Persistence Market Research社の調査で網羅的に説明されています。この調査レポートは、トキソプラズマ症検査の需要と調査期間中の定量的な発展機会を知る読者を支援することができます。 本調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなど、ランドスケープにおける株主にとって有益であり、トキソプラズマ症検査市場で繁栄するための適切な事業戦略を策定する際に役立ちます。トキソプラズマ症検査市場の株主、業界専門家、投資家、研究者、報道関係者、ビジネス愛好家は、このPersistence Market Researchの調査レポートで紹介されている洞察や情報を活用することができます。 市場統計、ならびにトキソプラズマ症検査市場のビジネスシナリオに影響を与えるマクロ経済変数およびマクロ経済変数に関連する情報も、この調査には含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートに記載されています。さらに、本レポートで提出されたデータによって、業界のマイナー企業や新規参入企業は、市場で牽引力を発揮するために適切な企業選択を行う際に役立ちます。 主要市場セグメント Persistence Market Research社のトキソプラズマ症検査市場に関する調査レポートは、検査タイプ、サンプル、エンドユーザー、地域の4つの重要なセグメントに分けた情報を提供しています。本レポートは、これらのカテゴリに関連する重要な市場ダイナミクスと成長パラメータに関する包括的なデータと情報を提供します。 属性の詳細 検査タイプ エロロジー検査 染色検査 間接凝集アッセイ 直接凝集測定法 ELISA法 PCR法 超音波検査 MRI 生検 サンプル 血液サンプル 羊水 脳脊髄液 エンドユーザー 病院 診療所 診断研究所 地域 北米 ラテンアメリカ ヨーロッパ 南アジア 東アジア オセアニア 中東・アフリカ（MEA） レポートで回答した主な質問 今後数年間、トキソプラズマ症検査で最も収益性の高い市場であり続けるのはどの地域か？ トレンドの変化は市場にどのような影響を与えるか？ 市場プレイヤーは先進地域でどのように低空飛行の機会を捉えることができるか？ このような状況において、利害関係者はどのような戦略で自らのポジションを確立しているのか？ 投資家が市場に投資する際に注意すべき、また取り組む可能性のある阻害要因は何か？ 市場に影響を与える開発動向は何か？ トキソプラズマ症検査市場の企業は、先進国および新興国の成長機会をどのように利用できるか？ 調査方法 Persistence Market Research社の調査レポートでは、トキソプラズマ症検査市場の成長に関する広範な調査を実施し、市場の今後の成長パラメータに関する結論を得るために、独自の調査手法を活用しています。この調査手法は一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。 市場調査作成中にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行った。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、トキソプラズマ症検査市場の成長見通しに関するPersistence Market Research社の予測をより正確で信頼性の高いものにしています。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Product Usage Analysis 4.3. Regulatory Framework 4.4. Recent Product Approvals/Launches 4.5. Porter’s Analysis 4.6. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Per Capita Healthcare Spending 5.1.2. Global Life Expectancy Outlook 5.1.3. Global Research and Development Funding Outlook 5.1.4. Global Infectious Disease Testing Market (Parent Market Analysis) 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing prevalence of toxoplasmosis 5.2.2. Evolving healthcare policies and clinical guidelines 5.2.3. Advancements in Diagnostic Technologies 5.2.4. Research and Development 5.2.5. Public Health Campaigns 5.2.6. Pregnancy Care Emphasis 5.2.7. Regulatory Approvals 5.2.8. Patient Awareness and Education 5.2.9. Emerging Healthcare Markets 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033 6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 6.2. Historical Market Value (US$ Million) Analysis, 2012 to 2022 6.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 6.3.1. Y-o-Y Growth Trend Analysis 6.3.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Test Type 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Million) Analysis By Test Type, 2012 to 2022 7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033 7.3.1. Serological Test 7.3.1.1. Dye Test 7.3.1.2. Indirect Hemagglutination Assay 7.3.1.3. Direct agglutination Assay 7.3.2. ELISA 7.3.3. PCR 7.3.4. Ultrasound 7.3.5. MRI 7.3.6. Biopsy 7.4. Market Attractiveness Analysis By Test Type 8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis, By Sample, 2012 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample, 2023 to 2033 8.3.1. Blood Sample 8.3.2. Amniotic Fluid 8.3.3. Cerebrospinal Fluid 8.4. Market Attractiveness Analysis By Sample 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 9.3.1. Hospitals 9.3.2. Clinics 9.3.3. Diagnostic Laboratories 9.4. Market Attractiveness Analysis By End User 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis, By Region, 2012 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. South Asia 10.3.5. East Asia 10.3.6. Oceania 10.3.7. Middle East & Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 11.3.1. By Country 11.3.1.1. United States 11.3.1.2. Canada 11.3.2. By Test Type 11.3.3. By Sample 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Test Type 11.4.3. By Sample 11.4.4. By End User 11.5. Market Trends 11.6. Market Drivers & Restraints – Impact Analysis 11.7. Country Level Analysis & Forecast 11.7.1. United States Market 11.7.1.1. Introduction 11.7.1.2. Market Analysis and Forecast by Market Taxonomy 11.7.1.2.1. By Test Type 11.7.1.2.2. By Sample 11.7.1.2.3. By End User 11.7.2. Canada Market 11.7.2.1. Introduction 11.7.2.2. Market Analysis and Forecast by Market Taxonomy 11.7.2.2.1. By Test Type 11.7.2.2.2. By Sample 11.7.2.2.3. By End User 12. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of LATAM 12.3.2. By Test Type 12.3.3. By Sample 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Test Type 12.4.3. By Sample 12.4.4. By End User 12.5. Market Trends 12.6. Market Drivers & Restraints – Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. Brazil Market 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast by Market Taxonomy 12.7.1.2.1. By Test Type 12.7.1.2.2. By Sample 12.7.1.2.3. By End User 12.7.2. Mexico Market 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast by Market Taxonomy 12.7.2.2.1. By Test Type 12.7.2.2.2. By Sample 12.7.2.2.3. By End User 12.7.3. Argentina Market 12.7.3.1. Introduction 12.7.3.2. Market Analysis and Forecast by Market Taxonomy 12.7.3.2.1. By Test Type 12.7.3.2.2. By Sample 12.7.3.2.3. By End User 13. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. United Kingdom 13.3.1.2. Germany 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Rest of Europe 13.3.2. By Test Type 13.3.3. By Sample 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Test Type 13.4.3. By Sample 13.4.4. By End User 13.5. Market Trends 13.6. Market Drivers & Restraints – Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. United Kingdom Market 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Test Type 13.7.1.2.2. By Sample 13.7.1.2.3. By End User 13.7.2. Germany Market 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Test Type 13.7.2.2.2. By Sample 13.7.2.2.3. By End User 13.7.3. France Market 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast by Market Taxonomy 13.7.3.2.1. By Test Type 13.7.3.2.2. By Sample 13.7.3.2.3. By End User 13.7.4. Italy Market 13.7.4.1. Introduction 13.7.4.2. Market Analysis and Forecast by Market Taxonomy 13.7.4.2.1. By Test Type 13.7.4.2.2. By Sample 13.7.4.2.3. By End User 13.7.5. Spain Market 13.7.5.1. Introduction 13.7.5.2. Market Analysis and Forecast by Market Taxonomy 13.7.5.2.1. By Test Type 13.7.5.2.2. By Sample 13.7.5.2.3. By End User 13.7.6. BENELUX Market 13.7.6.1. Introduction 13.7.6.2. Market Analysis and Forecast by Market Taxonomy 13.7.6.2.1. By Test Type 13.7.6.2.2. By Sample 13.7.6.2.3. By End User 13.7.7. Russia Market 13.7.7.1. Introduction 13.7.7.2. Market Analysis and Forecast by Market Taxonomy 13.7.7.2.1. By Test Type 13.7.7.2.2. By Sample 13.7.7.2.3. By End User 14. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Test Type 14.3.3. By Sample 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Test Type 14.4.3. By Sample 14.4.4. By End User 14.5. Market Trends 14.6. Market Drivers & Restraints – Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. China Market 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Test Type 14.7.1.2.2. By Sample 14.7.1.2.3. By End User 14.7.2. Japan Market 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Test Type 14.7.2.2.2. By Sample 14.7.2.2.3. By End User 14.7.3. South Korea Market 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast by Market Taxonomy 14.7.3.2.1. By Test Type 14.7.3.2.2. By Sample 14.7.3.2.3. By End User 15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Indonesia 15.3.1.3. Thailand 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Test Type 15.3.3. By Sample 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Test Type 15.4.3. By Sample 15.4.4. By End User 15.5. Market Trends 15.6. Market Drivers & Restraints – Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. India Market 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Test Type 15.7.1.2.2. By Sample 15.7.1.2.3. By End User 15.7.2. Indonesia Market 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Test Type 15.7.2.2.2. By Sample 15.7.2.2.3. By End User 15.7.3. Thailand Market 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Test Type 15.7.3.2.2. By Sample 15.7.3.2.3. By End User 15.7.4. Malaysia Market 15.7.4.1. Introduction 15.7.4.2. Market Analysis and Forecast by Market Taxonomy 15.7.4.2.1. By Test Type 15.7.4.2.2. By Sample 15.7.4.2.3. By End User 16. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Test Type 16.3.3. By Sample 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Test Type 16.4.3. By Sample 16.4.4. By End User 16.5. Market Trends 16.6. Market Drivers & Restraints – Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. Australia Market 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Test Type 16.7.1.2.2. By Sample 16.7.1.2.3. By End User 16.7.2. New Zealand Market 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Test Type 16.7.2.2.2. By Sample 16.7.2.2.3. By End User 17. Middle East & Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Türkiye 17.3.1.3. South Africa 17.3.1.4. Northern Africa 17.3.1.5. Rest of Middle East and Africa 17.3.2. By Test Type 17.3.3. By Sample 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Test Type 17.4.3. By Sample 17.4.4. By End User 17.5. Market Trends 17.6. Market Drivers & Restraints – Impact Analysis 17.7. Country Level Analysis & Forecast 17.7.1. GCC Countries Market 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Test Type 17.7.1.2.2. By Sample 17.7.1.2.3. By End User 17.7.2. Türkiye Market 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Test Type 17.7.2.2.2. By Sample 17.7.2.2.3. By End User 17.7.3. South Africa Market 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Test Type 17.7.3.2.2. By Sample 17.7.3.2.3. By End User 17.7.4. Northern Africa Market 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Test Type 17.7.4.2.2. By Sample 17.7.4.2.3. By End User 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies (Maternity Care Products) 18.2. Market Share Analysis of Top Players 18.3. Market Concentration 19. Competition Analysis 19.1. Competition Dashboard 19.2. Branding and Promotional Strategies, By key Players 19.3. Key Development Analysis 19.4. Competition Deep Dive 19.4.1. Abbott Laboratories 19.4.1.1. Overview 19.4.1.2. Product Portfolio 19.4.1.3. Key Financials 19.4.1.4. SWOT Analysis 19.4.1.5. Key Developments 19.4.1.6. Sales Footprint 19.4.1.7. Strategy Overview 19.4.1.7.1. Marketing Strategy 19.4.1.7.2. Product Strategy 19.4.1.7.3. Channel Strategy 19.4.2. Bio-Rad Laboratories Inc 19.4.2.1. Overview 19.4.2.2. Product Portfolio 19.4.2.3. Key Financials 19.4.2.4. SWOT Analysis 19.4.2.5. Key Developments 19.4.2.6. Sales Footprint 19.4.2.7. Strategy Overview 19.4.2.7.1. Marketing Strategy 19.4.2.7.2. Product Strategy 19.4.2.7.3. Channel Strategy 19.4.3. Affymetrix Inc. 19.4.3.1. Overview 19.4.3.2. Product Portfolio 19.4.3.3. Key Financials 19.4.3.4. SWOT Analysis 19.4.3.5. Key Developments 19.4.3.6. Sales Footprint 19.4.3.7. Strategy Overview 19.4.3.7.1. Marketing Strategy 19.4.3.7.2. Product Strategy 19.4.3.7.3. Channel Strategy 19.4.4. Beckman Coulter Inc. 19.4.4.1. Overview 19.4.4.2. Product Portfolio 19.4.4.3. Key Financials 19.4.4.4. SWOT Analysis 19.4.4.5. Key Developments 19.4.4.6. Sales Footprint 19.4.4.7. Strategy Overview 19.4.4.7.1. Marketing Strategy 19.4.4.7.2. Product Strategy 19.4.4.7.3. Channel Strategy 19.4.5. Biotest 19.4.5.1. Overview 19.4.5.2. Product Portfolio 19.4.5.3. Key Financials 19.4.5.4. SWOT Analysis 19.4.5.5. Key Developments 19.4.5.6. Sales Footprint 19.4.5.7. Strategy Overview 19.4.5.7.1. Marketing Strategy 19.4.5.7.2. Product Strategy 19.4.5.7.3. Channel Strategy 19.4.6. Cepheid Inc. 19.4.6.1. Overview 19.4.6.2. Product Portfolio 19.4.6.3. Key Financials 19.4.6.4. SWOT Analysis 19.4.6.5. Key Developments 19.4.6.6. Sales Footprint 19.4.6.7. Strategy Overview 19.4.6.7.1. Marketing Strategy 19.4.6.7.2. Product Strategy 19.4.6.7.3. Channel Strategy 19.4.7. GenBio 19.4.7.1. Overview 19.4.7.2. Product Portfolio 19.4.7.3. Key Financials 19.4.7.4. SWOT Analysis 19.4.7.5. Key Developments 19.4.7.6. Sales Footprint 19.4.7.7. Strategy Overview 19.4.7.7.1. Marketing Strategy 19.4.7.7.2. Product Strategy 19.4.7.7.3. Channel Strategy 19.4.8. Danaher Corporation 19.4.8.1. Overview 19.4.8.2. Product Portfolio 19.4.8.3. Key Financials 19.4.8.4. SWOT Analysis 19.4.8.5. Key Developments 19.4.8.6. Sales Footprint 19.4.8.7. Strategy Overview 19.4.8.7.1. Marketing Strategy 19.4.8.7.2. Product Strategy 19.4.8.7.3. Channel Strategy 19.4.9. Thermo Fisher Scientific 19.4.9.1. Overview 19.4.9.2. Product Portfolio 19.4.9.3. Key Financials 19.4.9.4. SWOT Analysis 19.4.9.5. Key Developments 19.4.9.6. Sales Footprint 19.4.9.7. Strategy Overview 19.4.9.7.1. Marketing Strategy 19.4.9.7.2. Product Strategy 19.4.9.7.3. Channel Strategy 19.4.10. Biomerica Inc. 19.4.10.1. Overview 19.4.10.2. Product Portfolio 19.4.10.3. Key Financials 19.4.10.4. SWOT Analysis 19.4.10.5. Key Developments 19.4.10.6. Sales Footprint 19.4.10.7. Strategy Overview 19.4.10.7.1. Marketing Strategy 19.4.10.7.2. Product Strategy 19.4.10.7.3. Channel Strategy 19.4.11. Biomerix 19.4.11.1. Overview 19.4.11.2. Product Portfolio 19.4.11.3. Key Financials 19.4.11.4. SWOT Analysis 19.4.11.5. Key Developments 19.4.11.6. Sales Footprint 19.4.11.7. Strategy Overview 19.4.11.7.1. Marketing Strategy 19.4.11.7.2. Product Strategy 19.4.11.7.3. Channel Strategy 20. Assumptions and Acronyms Used 21. Research Methodology
SummaryToxoplasmosis Testing Market: Report Scope Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption Analysis 4.2. Product Usage Analysis 4.3. Regulatory Framework 4.4. Recent Product Approvals/Launches 4.5. Porter’s Analysis 4.6. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Per Capita Healthcare Spending 5.1.2. Global Life Expectancy Outlook 5.1.3. Global Research and Development Funding Outlook 5.1.4. Global Infectious Disease Testing Market (Parent Market Analysis) 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing prevalence of toxoplasmosis 5.2.2. Evolving healthcare policies and clinical guidelines 5.2.3. Advancements in Diagnostic Technologies 5.2.4. Research and Development 5.2.5. Public Health Campaigns 5.2.6. Pregnancy Care Emphasis 5.2.7. Regulatory Approvals 5.2.8. Patient Awareness and Education 5.2.9. Emerging Healthcare Markets 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033 6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic 6.2. Historical Market Value (US$ Million) Analysis, 2012 to 2022 6.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 6.3.1. Y-o-Y Growth Trend Analysis 6.3.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Test Type 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Million) Analysis By Test Type, 2012 to 2022 7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033 7.3.1. Serological Test 7.3.1.1. Dye Test 7.3.1.2. Indirect Hemagglutination Assay 7.3.1.3. Direct agglutination Assay 7.3.2. ELISA 7.3.3. PCR 7.3.4. Ultrasound 7.3.5. MRI 7.3.6. Biopsy 7.4. Market Attractiveness Analysis By Test Type 8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis, By Sample, 2012 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample, 2023 to 2033 8.3.1. Blood Sample 8.3.2. Amniotic Fluid 8.3.3. Cerebrospinal Fluid 8.4. Market Attractiveness Analysis By Sample 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 9.3.1. Hospitals 9.3.2. Clinics 9.3.3. Diagnostic Laboratories 9.4. Market Attractiveness Analysis By End User 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis, By Region, 2012 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. South Asia 10.3.5. East Asia 10.3.6. Oceania 10.3.7. Middle East & Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 11.3.1. By Country 11.3.1.1. United States 11.3.1.2. Canada 11.3.2. By Test Type 11.3.3. By Sample 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Test Type 11.4.3. By Sample 11.4.4. By End User 11.5. Market Trends 11.6. Market Drivers & Restraints – Impact Analysis 11.7. Country Level Analysis & Forecast 11.7.1. United States Market 11.7.1.1. Introduction 11.7.1.2. Market Analysis and Forecast by Market Taxonomy 11.7.1.2.1. By Test Type 11.7.1.2.2. By Sample 11.7.1.2.3. By End User 11.7.2. Canada Market 11.7.2.1. Introduction 11.7.2.2. Market Analysis and Forecast by Market Taxonomy 11.7.2.2.1. By Test Type 11.7.2.2.2. By Sample 11.7.2.2.3. By End User 12. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of LATAM 12.3.2. By Test Type 12.3.3. By Sample 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Test Type 12.4.3. By Sample 12.4.4. By End User 12.5. Market Trends 12.6. Market Drivers & Restraints – Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. Brazil Market 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast by Market Taxonomy 12.7.1.2.1. By Test Type 12.7.1.2.2. By Sample 12.7.1.2.3. By End User 12.7.2. Mexico Market 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast by Market Taxonomy 12.7.2.2.1. By Test Type 12.7.2.2.2. By Sample 12.7.2.2.3. By End User 12.7.3. Argentina Market 12.7.3.1. Introduction 12.7.3.2. Market Analysis and Forecast by Market Taxonomy 12.7.3.2.1. By Test Type 12.7.3.2.2. By Sample 12.7.3.2.3. By End User 13. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. United Kingdom 13.3.1.2. Germany 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Rest of Europe 13.3.2. By Test Type 13.3.3. By Sample 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Test Type 13.4.3. By Sample 13.4.4. By End User 13.5. Market Trends 13.6. Market Drivers & Restraints – Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. United Kingdom Market 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Test Type 13.7.1.2.2. By Sample 13.7.1.2.3. By End User 13.7.2. Germany Market 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Test Type 13.7.2.2.2. By Sample 13.7.2.2.3. By End User 13.7.3. France Market 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast by Market Taxonomy 13.7.3.2.1. By Test Type 13.7.3.2.2. By Sample 13.7.3.2.3. By End User 13.7.4. Italy Market 13.7.4.1. Introduction 13.7.4.2. Market Analysis and Forecast by Market Taxonomy 13.7.4.2.1. By Test Type 13.7.4.2.2. By Sample 13.7.4.2.3. By End User 13.7.5. Spain Market 13.7.5.1. Introduction 13.7.5.2. Market Analysis and Forecast by Market Taxonomy 13.7.5.2.1. By Test Type 13.7.5.2.2. By Sample 13.7.5.2.3. By End User 13.7.6. BENELUX Market 13.7.6.1. Introduction 13.7.6.2. Market Analysis and Forecast by Market Taxonomy 13.7.6.2.1. By Test Type 13.7.6.2.2. By Sample 13.7.6.2.3. By End User 13.7.7. Russia Market 13.7.7.1. Introduction 13.7.7.2. Market Analysis and Forecast by Market Taxonomy 13.7.7.2.1. By Test Type 13.7.7.2.2. By Sample 13.7.7.2.3. By End User 14. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Test Type 14.3.3. By Sample 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Test Type 14.4.3. By Sample 14.4.4. By End User 14.5. Market Trends 14.6. Market Drivers & Restraints – Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. China Market 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Test Type 14.7.1.2.2. By Sample 14.7.1.2.3. By End User 14.7.2. Japan Market 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Test Type 14.7.2.2.2. By Sample 14.7.2.2.3. By End User 14.7.3. South Korea Market 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast by Market Taxonomy 14.7.3.2.1. By Test Type 14.7.3.2.2. By Sample 14.7.3.2.3. By End User 15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Indonesia 15.3.1.3. Thailand 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Test Type 15.3.3. By Sample 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Test Type 15.4.3. By Sample 15.4.4. By End User 15.5. Market Trends 15.6. Market Drivers & Restraints – Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. India Market 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Test Type 15.7.1.2.2. By Sample 15.7.1.2.3. By End User 15.7.2. Indonesia Market 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Test Type 15.7.2.2.2. By Sample 15.7.2.2.3. By End User 15.7.3. Thailand Market 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Test Type 15.7.3.2.2. By Sample 15.7.3.2.3. By End User 15.7.4. Malaysia Market 15.7.4.1. Introduction 15.7.4.2. Market Analysis and Forecast by Market Taxonomy 15.7.4.2.1. By Test Type 15.7.4.2.2. By Sample 15.7.4.2.3. By End User 16. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Test Type 16.3.3. By Sample 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Test Type 16.4.3. By Sample 16.4.4. By End User 16.5. Market Trends 16.6. Market Drivers & Restraints – Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. Australia Market 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Test Type 16.7.1.2.2. By Sample 16.7.1.2.3. By End User 16.7.2. New Zealand Market 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Test Type 16.7.2.2.2. By Sample 16.7.2.2.3. By End User 17. Middle East & Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2012 to 2022 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Türkiye 17.3.1.3. South Africa 17.3.1.4. Northern Africa 17.3.1.5. Rest of Middle East and Africa 17.3.2. By Test Type 17.3.3. By Sample 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Test Type 17.4.3. By Sample 17.4.4. By End User 17.5. Market Trends 17.6. Market Drivers & Restraints – Impact Analysis 17.7. Country Level Analysis & Forecast 17.7.1. GCC Countries Market 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Test Type 17.7.1.2.2. By Sample 17.7.1.2.3. By End User 17.7.2. Türkiye Market 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Test Type 17.7.2.2.2. By Sample 17.7.2.2.3. By End User 17.7.3. South Africa Market 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Test Type 17.7.3.2.2. By Sample 17.7.3.2.3. By End User 17.7.4. Northern Africa Market 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Test Type 17.7.4.2.2. By Sample 17.7.4.2.3. By End User 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies (Maternity Care Products) 18.2. Market Share Analysis of Top Players 18.3. Market Concentration 19. Competition Analysis 19.1. Competition Dashboard 19.2. Branding and Promotional Strategies, By key Players 19.3. Key Development Analysis 19.4. Competition Deep Dive 19.4.1. Abbott Laboratories 19.4.1.1. Overview 19.4.1.2. Product Portfolio 19.4.1.3. Key Financials 19.4.1.4. SWOT Analysis 19.4.1.5. Key Developments 19.4.1.6. Sales Footprint 19.4.1.7. Strategy Overview 19.4.1.7.1. Marketing Strategy 19.4.1.7.2. Product Strategy 19.4.1.7.3. Channel Strategy 19.4.2. Bio-Rad Laboratories Inc 19.4.2.1. Overview 19.4.2.2. Product Portfolio 19.4.2.3. Key Financials 19.4.2.4. SWOT Analysis 19.4.2.5. Key Developments 19.4.2.6. Sales Footprint 19.4.2.7. Strategy Overview 19.4.2.7.1. Marketing Strategy 19.4.2.7.2. Product Strategy 19.4.2.7.3. Channel Strategy 19.4.3. Affymetrix Inc. 19.4.3.1. Overview 19.4.3.2. Product Portfolio 19.4.3.3. Key Financials 19.4.3.4. SWOT Analysis 19.4.3.5. Key Developments 19.4.3.6. Sales Footprint 19.4.3.7. Strategy Overview 19.4.3.7.1. Marketing Strategy 19.4.3.7.2. Product Strategy 19.4.3.7.3. Channel Strategy 19.4.4. Beckman Coulter Inc. 19.4.4.1. Overview 19.4.4.2. Product Portfolio 19.4.4.3. Key Financials 19.4.4.4. SWOT Analysis 19.4.4.5. Key Developments 19.4.4.6. Sales Footprint 19.4.4.7. Strategy Overview 19.4.4.7.1. Marketing Strategy 19.4.4.7.2. Product Strategy 19.4.4.7.3. Channel Strategy 19.4.5. Biotest 19.4.5.1. Overview 19.4.5.2. Product Portfolio 19.4.5.3. Key Financials 19.4.5.4. SWOT Analysis 19.4.5.5. Key Developments 19.4.5.6. Sales Footprint 19.4.5.7. Strategy Overview 19.4.5.7.1. Marketing Strategy 19.4.5.7.2. Product Strategy 19.4.5.7.3. Channel Strategy 19.4.6. Cepheid Inc. 19.4.6.1. Overview 19.4.6.2. Product Portfolio 19.4.6.3. Key Financials 19.4.6.4. SWOT Analysis 19.4.6.5. Key Developments 19.4.6.6. Sales Footprint 19.4.6.7. Strategy Overview 19.4.6.7.1. Marketing Strategy 19.4.6.7.2. Product Strategy 19.4.6.7.3. Channel Strategy 19.4.7. GenBio 19.4.7.1. Overview 19.4.7.2. Product Portfolio 19.4.7.3. Key Financials 19.4.7.4. SWOT Analysis 19.4.7.5. Key Developments 19.4.7.6. Sales Footprint 19.4.7.7. Strategy Overview 19.4.7.7.1. Marketing Strategy 19.4.7.7.2. Product Strategy 19.4.7.7.3. Channel Strategy 19.4.8. Danaher Corporation 19.4.8.1. Overview 19.4.8.2. Product Portfolio 19.4.8.3. Key Financials 19.4.8.4. SWOT Analysis 19.4.8.5. Key Developments 19.4.8.6. Sales Footprint 19.4.8.7. Strategy Overview 19.4.8.7.1. Marketing Strategy 19.4.8.7.2. Product Strategy 19.4.8.7.3. Channel Strategy 19.4.9. Thermo Fisher Scientific 19.4.9.1. Overview 19.4.9.2. Product Portfolio 19.4.9.3. Key Financials 19.4.9.4. SWOT Analysis 19.4.9.5. Key Developments 19.4.9.6. Sales Footprint 19.4.9.7. Strategy Overview 19.4.9.7.1. Marketing Strategy 19.4.9.7.2. Product Strategy 19.4.9.7.3. Channel Strategy 19.4.10. Biomerica Inc. 19.4.10.1. Overview 19.4.10.2. Product Portfolio 19.4.10.3. Key Financials 19.4.10.4. SWOT Analysis 19.4.10.5. Key Developments 19.4.10.6. Sales Footprint 19.4.10.7. Strategy Overview 19.4.10.7.1. Marketing Strategy 19.4.10.7.2. Product Strategy 19.4.10.7.3. Channel Strategy 19.4.11. Biomerix 19.4.11.1. Overview 19.4.11.2. Product Portfolio 19.4.11.3. Key Financials 19.4.11.4. SWOT Analysis 19.4.11.5. Key Developments 19.4.11.6. Sales Footprint 19.4.11.7. Strategy Overview 19.4.11.7.1. Marketing Strategy 19.4.11.7.2. Product Strategy 19.4.11.7.3. Channel Strategy 20. Assumptions and Acronyms Used 21. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート
本レポートと同じKEY WORD（account）の最新刊レポートよくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/19 10:26 155.94 円 162.31 円 199.02 円 |
